Login to Your Account



Trimeris, Roche Increase Capacity For Fuzeon, Release More Data

By Aaron Lorenzo


Wednesday, July 16, 2003
Reports of increased global supplies of Fuzeon, coupled with longer-term data on the product, gave Trimeris Inc. a boost from investors eyeing higher earnings from early sales of the FDA-approved HIV drug. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription